Innovation, Nontraditional Antibacterial Drugs, and Clinical Utility-Reference-Cited by-同舟云学术

Innovation, Nontraditional Antibacterial Drugs, and Clinical Utility

Published:2021-05-12 Issue:8 Volume:7 Page:2027-2028
ISSN:2373-8227
Container-title:ACS Infectious Diseases
language:en
Short-container-title:ACS Infect. Dis.

Author:

Shlaes David M.¹^ORCID

Affiliation:

1. Anti-infectives Consulting, Stonington, Connecticut 06378, United States

Publisher

American Chemical Society (ACS)

Subject

Infectious Diseases

Link

https://pubs.acs.org/doi/pdf/10.1021/acsinfecdis.1c00227

Reference11 articles.

1. Shlaes, D. M. Antibiotics – Innovation or Clinical Utility. https://antibiotics-theperfectstorm.blogspot.com/2019/11/antibiotics-innovation-or-clinical.html (accessed April 27, 2021).

2. Shlaes, D. M. Non-Traditional Antibacterials. https://antibiotics-theperfectstorm.blogspot.com/2019/03/non-traditional-antibacterials.html (accessed April 27, 2021).

3. The global preclinical antibacterial pipeline

4. Discovery of Taniborbactam (VNRX-5133): A Broad-Spectrum Serine- and Metallo-β-lactamase Inhibitor for Carbapenem-Resistant Bacterial Infections

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Review of Antibacterial Candidates with New Modes of Action;ACS Infectious Diseases;2024-07-17

2. In vitro activity of cefepime/taniborbactam and comparator agents against Gram-negative bacterial bloodstream pathogens recovered from patients with cancer;JAC-Antimicrobial Resistance;2024-03-05

3. Ceragenins and Ceragenin-Based Core-Shell Nanosystems as New Antibacterial Agents against Gram-Negative Rods Causing Nosocomial Infections;Pathogens;2023-11-13

4. Antibiotics in the clinical pipeline as of December 2022;The Journal of Antibiotics;2023-06-08

5. Emerging Target-Directed Approaches for the Treatment and Diagnosis of Microbial Infections;Journal of Medicinal Chemistry;2022-12-31